Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sudden Infant Death | 2 | 2019 | 7 | 0.640 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2012 | 14 | 0.610 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 192 | 0.600 |
Why?
|
| Child Development | 1 | 2019 | 99 | 0.580 |
Why?
|
| Nerve Net | 1 | 2019 | 101 | 0.570 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 126 | 0.570 |
Why?
|
| Homeostasis | 1 | 2019 | 192 | 0.560 |
Why?
|
| Chemoreceptor Cells | 4 | 2006 | 19 | 0.520 |
Why?
|
| Endocannabinoids | 1 | 2016 | 41 | 0.480 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 91 | 0.450 |
Why?
|
| Cannabis | 1 | 2016 | 90 | 0.430 |
Why?
|
| Inflammation | 1 | 2019 | 758 | 0.420 |
Why?
|
| Models, Animal | 1 | 2011 | 151 | 0.320 |
Why?
|
| Arteries | 3 | 2006 | 81 | 0.320 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 252 | 0.320 |
Why?
|
| Infant, Newborn | 4 | 2019 | 972 | 0.260 |
Why?
|
| Rats | 6 | 2006 | 3735 | 0.250 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2006 | 2 | 0.240 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2006 | 4 | 0.240 |
Why?
|
| Carotid Body | 5 | 2006 | 7 | 0.240 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 300 | 0.240 |
Why?
|
| Narcotics | 1 | 2006 | 29 | 0.240 |
Why?
|
| Ganglia, Sensory | 1 | 2004 | 4 | 0.220 |
Why?
|
| Central Nervous System | 1 | 2006 | 152 | 0.220 |
Why?
|
| Receptors, Cannabinoid | 1 | 2004 | 31 | 0.220 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2002 | 5 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 830 | 0.190 |
Why?
|
| Pregnancy | 4 | 2016 | 1772 | 0.190 |
Why?
|
| Receptors, Nicotinic | 1 | 2002 | 114 | 0.180 |
Why?
|
| Lead | 1 | 2002 | 100 | 0.170 |
Why?
|
| Nodose Ganglion | 3 | 2006 | 4 | 0.170 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 1596 | 0.160 |
Why?
|
| Animals, Newborn | 4 | 2005 | 352 | 0.120 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.110 |
Why?
|
| Mice | 1 | 2006 | 6644 | 0.110 |
Why?
|
| Brain | 1 | 2002 | 1472 | 0.110 |
Why?
|
| Animals | 7 | 2011 | 16992 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2006 | 1766 | 0.100 |
Why?
|
| Humans | 6 | 2019 | 43102 | 0.100 |
Why?
|
| Methadone | 1 | 2012 | 24 | 0.100 |
Why?
|
| Buprenorphine | 1 | 2012 | 51 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2012 | 144 | 0.090 |
Why?
|
| Female | 4 | 2016 | 24698 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1271 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 58 | 0.060 |
Why?
|
| Age Factors | 2 | 2006 | 1154 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2005 | 44 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 135 | 0.060 |
Why?
|
| Apnea | 1 | 2004 | 8 | 0.050 |
Why?
|
| Superior Cervical Ganglion | 1 | 2004 | 4 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 65 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2004 | 77 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 934 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 65 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 38 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 109 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2002 | 108 | 0.050 |
Why?
|
| Pyridines | 1 | 2002 | 139 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2002 | 256 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1124 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2005 | 92 | 0.030 |
Why?
|
| Rhodamines | 1 | 2005 | 22 | 0.010 |
Why?
|
| Dextrans | 1 | 2005 | 29 | 0.010 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 12 | 0.010 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2004 | 36 | 0.010 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2004 | 53 | 0.010 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2004 | 7 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 575 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 48 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 134 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 218 | 0.010 |
Why?
|
| Male | 1 | 2002 | 23409 | 0.010 |
Why?
|
| Dopamine | 1 | 2004 | 275 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 302 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 701 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3994 | 0.010 |
Why?
|